Immunotherapeutic effects of T11TS/S-LFA3 against nitrosocompound mediated neural genotoxicity

Toxicology Letters

Volumn 150, Issue 3, 2004, Pages 239-257

  Mukherjee, Joydeep ^a   Sarkar, Susobhan ^a   Ghosh, Anirban ^a   Duttagupta, Ashish Kumar ^b   Chaudhuri, Samares ^c   Chaudhuri, Swapna ^a  

^a INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

^b UNIVERSITY OF CALCUTTA   (India)

^c CALCUTTA SCHOOL OF TROPICAL MEDICINE   (India)

Author keywords

Apoptosis; Immunotherapy; Neurotoxicity; Nitrosocompound; T11TS S LFA3

Indexed keywords

ANTINEOPLASTIC AGENT; ANTITOXIN; DNA; ETHYLNITROSOUREA; GLYCOPEPTIDE; IMMUNOMODULATING AGENT; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BODY GROWTH; BRAIN CANCER; CANCER CELL; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; DNA DAMAGE; DRUG EFFECT; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENOTOXICITY; IMMUNOLOGICAL PARAMETERS; IMMUNOTHERAPY; KINETICS; MALE; NEUROTOXICITY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; SHEEP ERYTHROCYTE;

ADJUVANTS, IMMUNOLOGIC; AGE FACTORS; ANIMALS; ANTIGENS, CD2; ANTIGENS, CD58; APOPTOSIS; BRAIN; BRAIN NEOPLASMS; DISEASE MODELS, ANIMAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ERYTHROCYTES; ETHYLNITROSOUREA; FEMALE; LYMPHOCYTES; MALE; MUTAGENS; PHAGOCYTOSIS; RATS; ROSETTE FORMATION; SHEEP; SPLEEN;

ANIMALIA; OVIS ARIES; RODENTIA;

EID: 1942452929     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2004.01.016     Document Type: Article

References (55)

1. Bachmann M.F., Barner M., Kopf M. CD2 sets quantitative thresholds in T-cell activation. J. Exp. Med. 190:1999;1383-1391.
2. Basu S., Chaudhuri S., Roy B. Surface ultrastructural changes of percoll separated splenic lymphocytes from syngenic and allogenic mice with transplantable ascitic fibrosarcoma tumor. Indian J. Exp. Biol. 20:1982;277-281.
3. Bartsch, H. 1991. N-nitrosocompounds and human cancer: where do we stand? In: O'Neill, I., Chen J., Bartsch, H. (Eds.), Relevance to Human Cancer of N-nitrosocompounds: Tobacco Smoke and Mycotoxins. Vol. 105, IARC Scientific Publications, Lyon, pp. 1-10.
4. Beranek D.T. Distribution of methyl and alkyl adducts following alkylation with monofunctional alkylating agents. Mutat. Res. 231:1990;11-30.
5. Boduer S., Strommer K., Frei K. Immunosupression and transforming growth factor beta in glioblastoma: preferential production of transforming growth factor-beta2. J. Immunol. 143:1989;3222-3229.
6. Boussiotis V.A., Freeman G.J., Griffin J.D., Gray G.S., Gribben J.G., Nadler L.M. CD2 is involved in maintenance and reversal of human alloantigen-specific clonal anergy. J. Exp. Med. 180:1994;1665-1673.
7. Brand K., Fekl W., Von Hintzenstern J., Langer K., Luppa P., Schoerner C. Metabolism of glutamine in lymphocytes. Metabolism. 8:1989;29-33.
8. Chaudhuri S., Sinha A., Sengupta A., Chaudhuri S. Sheep erythrocytes provides metabolic triggers for tumor phagocytosis in polymorphonuclear neutrophils: a possible mechanism of tumor intibition in mice. Biochem. Int. 23(20):1991;231-241.
9. Chaudhuri S., Ganguly S., Ghosh S.N., Dutta S., Sarkar S., Begum Z., Roy R.U., Bhattacharya M.K., Dutta S.K., Chaudhuri S. Immunological insurgence during intracranial tumor development: cellular immunity in astrocytoma patients. J. Physiol. Appl. Sci. 54(3):2000;118-129.
10. Darzynkiewicz Z., Bruno S., Del Bino G., Gorezyca W., Hotz M.A., Lassota P., Traganos F. Feature of apoptotic cells measured by flowcytometry. Cytometry. 13:1992;795-808.
11. Dustin M.L., Selvaraj, P., Mattaliano R.J., Springer T.A., 1987. Purified lymphocyte function-associated antigen 3 binds to CD2 and mediates T-lymphocyte adhesion. J. Exp. Med. 165:677-687.
12. Ebert E.C. Sheep red blood cells enhance T-lymphocytes proliferation. Clin. Immunol. Immunopathol. 37(2):1985;203-212.
13. - populations. J. Immunol. 134:1985;330-335.
14. Gangopaddhyay S.K., Sarkar S., Begum Z., Chaudhuri S., Chaudhuri S. Brain tumor inhibition in experimental model by restorative immunotherapy with a corpuscular antigen. Indian J. Exp. Biol. 45:2002;812-815.
15. Gutierrez M., Froster F.I., Mc Conell S.A., Cassidy J.P., Pollock J.M., Bryson D.G. The detection CD4+, CD8+, and WC1+ T-lymphocytes, B-cells and macrophages in fixed and paraffin embedded brain tissue using a range of antigen recovery and amplification techniques. Vet. Immunol. Immunopathol. 71(3-4):1999;321-334.
16. Hecht S.S., Hoffmann D. The relevance of tobacco specific nitrosoamines to human cancer. Cancer Surv. 8:1989;273-294.
17. Hishii M., Nitta T., Ishida H. Human glioma derived interleukin-10 inhibits anti-tumor immune responses in vitro. Neurosurgery. 37:1995;1160-1166.
18. Hotkiss J.H. Preformed N-nitroso compounds in foods and beverages. Cancer Surv. 8:1989;295-321.
19. Hudson, L., Hay, F.C., 1989. Cell Dynamics in vivo. Practical Immunology. Blackwell Scientific Publications, Oxford, pp. 182-206.
20. Ishizawa A. Immunotherapy for malignant gliomas. Neurol. Med. Chirugica (Tokyo). 21:1981;179-191.
21. Jacobs S.K., Wilson D.I., Koanblith P.L., Grimm E.A. Interleukin -2 or autologous lymphokine activated killer cell treatment of malignant glioma: phase I trial. Cancer Res. 46:1986;2102-2104.
22. Kantor, A.B., Roederer, M., 1996. FACS analysis of leucocytes. In: Herzenberg, L., Weir, D.M., Herzenberg, L., Blackwell, C. (Eds.), Weir's Handbook of Experimental Immunology, Vol. 2, Blackwell Science, USA, pp. 49.1-49.13.
23. Kitao T., Takeshita M., Hattori K. Studies on glycopeptide released by trypsin from sheep erythrocytes. J. Immunol. 117:1976;310-312.
24. Kleihues, P., Meer, I., Wrestler, O.D., Bamberg, M., 1987. Formation and repair of O-alkylated DNA bases: role in neurocarcinogenesis and chemotherapy. In: Grundmann, E. (Eds.), Cancer campaign, Experimental Neurooncology, Brain Tumor and Pain Therapy, Vol. 10, Gustav Fischer, Stuttgart, York, pp. 1-17.
25. Kleihues P., Doerjer G., Swenberg J.A. DNA repair as regulatory factor in the organotrophy of alkylating carcinogens. Arch.Toxicol. Suppl. 2:1979;253-262.
26. Koestner A., Swenberg J.A., Wechsler W. Transplacental production with ethylnitrosourea of neoplasms of the nervous system in Sprague-Dawley rats. A.M.J. Pathol. 63:1971;37-39.
27. Kuppner M.C., Sawamura Y., Hansou M.E. Influence of PGE-2 and Camp modulating agents on human gliuoblastoma cell killing by interleukin-2 activated lymphocytes. J. Neurosurg. 72:1990;617-619.
28. Laemmli U.K. Clevage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-682.
29. Lantos, P.L., Vanderberg, S.R., Kleihues, P., 2000. Tumors of the nervous system. In: Graham, D., Lantos, P.L. (Eds.), Greenfield's Neuropathology, 6th Edition, pp. 583-600.
30. Lantos, P.L. 1993. Chemical induction of tumors in nervous system. In: Thomas G.T. (Ed.), Neurooncology. Curchill Livingstone, New York, pp. 85-107.
31. Law S., Maiti D., Palit A., Majumder D., Basu K., Chaudhuri S., Chaudhuri S. Facilitation of functional compartmentalization of bone marrow cells in leukemic mice by biological response modifiers: an immunotherapeutic approach. Immunol. Lett. 76:2001;145-152.
32. Liu, Y., Ng, K.Y., Llillehei, K.O., 2000. Time course analysis and modulating effects of established brain tumor on active-specific Immunotherapy, Neurosurg. Focus 9 (6), 1.
33. Lowry O.H., Rosebrough N.J., Farr A.L., Randell R.J. Protein measurement with the folin-phenol reagent. J. Biol. Chem. 193:1951;265-275.
34. Magee P.N., Barnes H.J.M. Carcinogenic nitrosocompounds. Adv. Cancer Res. 10:1967;163-246.
35. Maniatis, T., Frirsch, E. F., Sambrook, J., 1982. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory.
36. Marletta M.A. Mammalian synthesis of nitrite, nitrate, nitric oxide and n-nitrosating agents. Chem. Res. Toxicol. 1:1988;273-294.
37. Meuer S.C., Hussey R.E., Fabbi M. An alternative pathway of T-cell activation: a functional role for the 50 Kd T11 sheep erythrocyte receptor protein. Cell. 36:1984;897-906.
38. Moingeon P., Chang H.C., Wallner B.P., Benessow S., Stebbins C., Frey A.Z., Reinherz E.L. CD2-mediated adhesion facilitates T-lymphocyte antigen recognition function. Nature. 339:1989;312-314.
39. Nicoletti I., Migliorati G., Pagliacci M.C., Gignani F., Riccardi C. A rapid and simple method for measuring thymocytes apoptosis by propidium iodide staining and flowcytometry. J. Immunol. Meth. 139:1991;271-279.
40. Nakagawa Y., Kirakawa K., Ueda S., Suzuki K., Fukuma S., Kishida T., Imanishi J., Amagai T. Local administration of interferon for malignant brain tumors. Cancer Treatment Rep. 67:1985;833-835.
41. Niiazova O.P., Osipova S.O., Badalova N.S., Dekhkan-khodzhaeva N.A. Early and late E-rosetting forming neutrophils in persistent lambiasis. Med. Parasitol Mosk. 1:1995;43-47.
42. Pilkington,G.F., Lantos, P.L., 1993. Pathology of experimental brain tumors. In: Thomas, G.T. (Ed.), Neurooncology. Churchill Livingstone, New York, pp. 51-76.
43. Preston-Martin, S., 1991. Gliomas and meningiomas in men in Los Angeles county: investigation of exposures to N-nitrosocompounds. In: O'Neill, I., Chen, J., Bartsch, H. (Eds.), Revelance to Human Cancer of N-nitrosocompounds: Tobacco Smoke and Mycotoxins. Vol. 105, IARC Scientific Publications, Lyon, pp. 197-203.
44. Raha S.K., Dey S.K., Roy S.K. Anti-tumor activity of L-asparaginase from cylindrocarpon obstutisporum MB10 and its effect on the immune system. Biochem. Int. 21(6):1990;987-1000.
45. Redelman D. Simultaneous increased expression of E-rosette receptor (CD2, T11) and T-cell growth factor receptors on human T-lymphocytes during activation. Cytometry. 8(2):1987;170-183.
46. Roy, R.U., Sarkar, S., Dutta Chaudhuri, M., Dutta, S.K., Chaudhuri, Swapna, Chaudhuri, S., 1997. Antigen presenting capacity of mononuclear phagocytes in experimental Leukemia and in patients with haematological malignancies in India. J. Haematol Blood Transf. 15 (1), 33.
47. Russell, D.S., Rubinstein, L.J., 1990. Experimental tumors of the nervous system. In: Rubinstein, L.J. (Ed.), Pathology of Tumors of the Nervous System. Edward Arnold Publication, pp. 58-71.
48. Sarkar S., Begum Z., Dutta S., Chaudhuri S., Chaudhuri S. Sheep form of leucocyte function antigen-3 (T11TS) exerts immunostimulatory and anti-tumor activity against experimental brain tumor: a new approach to biological response modifier therapy. J. Clin. Exp. Can. Res. 21(1):2002;95-106.
49. Sgove R., Wick G. Methods for the detection of apoptosis. Arch. Allergy Immunol. 105:1994;327-332.
50. Siliciano R.F., Pratt J.C., Schmidt R.E. Activation of cytolytic T-lymphocyte and natural killer cell function through the T11 sheep erythrocyte binding protein. Nature. 317:1985;428-430.
51. Spanova, A., Kozubek, S., Pipalova, I., Ravchukova, B., Vojtiskova, M., 1995. Programmed cell death detected in mouse embryos and thymocytes after gamma and first neutron irradiation, Proc. Symp. Rad. Biol. Appl. Space Res. Brno 44-49.
52. Squier M.K.T., Cohen J.J. Cell mediated cytotoxic mechanisms. Curr. Opin. Immunol. 6:1994;447-452.
53. Stasiak-Barmuta A., Zak J., Wiwatowska U. E-rosetting test comparison with the flowcytometric method in CD2+ cell evaluation. Zaklad Alergologii Dzieciecej Academii Medycznej, ul. Waszyngtona. 17:1998;15-274.
54. Wilkinson M., Morris A.G. Role of the E receptor in interferon-gamma expression: sheep erythrocytes augment interferon-gamma production by human lymphocytes. Cell Immunol. 86(1):1984;109-117.
55. Xu G.P., Reed P.I. N-nitrosocompounds in fresh gastric juice and their relation to intragastric pH and nitrite employing an improved analytical methods. Carcinogenesis. 14:1993;2547-2551.